Centessa Pharmaceuticals Plc
(NASDAQ) CNTA
Centessa Pharmaceuticals Plc Financials at a Glance
Market Cap
$5.34B
Revenue (TTM)
$15.00M
Net Income (TTM)
$197.53M
EPS (TTM)
$-1.46
P/E Ratio
-27.25
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Price
$39.73
Volume
111,900
Open
$39.65
Price
$39.73
Volume
111,900
Open
$39.65
Previous Close
$39.73
Daily Range
$39.65 - $39.79
52-Week Range
$9.60 - $40.26
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Price
$39.73
Volume
111,900
Open
$39.65
Previous Close
$39.73
Daily Range
$39.65 - $39.79
52-Week Range
$9.60 - $40.26
CNTA News
CNTA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Centessa Pharmaceuticals Plc
Industry
Biotechnology
Sector
Health CareEmployees
118
CEO
Saurabh Saha, MD, PhD
Website
centessa.comHeadquarters
Altrincham, WA14 2DT, GB
CNTA Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-14%
Net Income Margin
-13%
Return on Equity
-43%
Return on Capital
-32%
Return on Assets
-29%
Earnings Yield
-3.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.34B
Shares Outstanding
134.42M
Volume
111.90K
Short Interest
0.00%
Avg. Volume
2.38M
Financials (TTM)
Gross Profit
$15.00M
Operating Income
$207.69M
EBITDA
$207.69M
Operating Cash Flow
$193.82M
Capital Expenditure
$371.00K
Free Cash Flow
$194.19M
Cash & ST Invst.
$294.58M
Total Debt
$7.57M
Centessa Pharmaceuticals Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$5.34B
N/A
Market Cap/Employee
$69.29M
N/A
Employees
77
N/A
Net Income
$66.16M
+40.6%
EBITDA
$88.00M
+18.2%
Quarterly Fundamentals
Net Cash
$287.01M
-21.4%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$7.57M
-93.5%
Short Term Debt
$0.00
N/A
Return on Assets
-28.73%
N/A
Return on Invested Capital
-32.22%
N/A
Free Cash Flow
$55.82M
-30.4%
Operating Cash Flow
$55.81M
-30.4%